Foxp3 + staining unveiled a significant (P < 0.0001) decline in the amount of tumor-associated immunosuppressive regulatory T-cells compared to controls, at both day 3 and 6 after 90Y-NM600 injection (Fig. 6c). This evidence concerns the gene FOXP3 and neoplasm.